ebitda
20.5–21 $billion
FY 2026
official guidance
ALPHA DHABI HOLDING
Loading chart…
OpenFilings analyst
Our analyst
Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.
Strong BuyBuyHoldSellStrong Sell
Attractive valuation and balance-sheet capacity are offset by weak underlying EBITDA growth, earnings concentration and non-cash gains.
HOLD: Alpha Dhabi delivered a strong Q1, with revenue up 8% YoY to AED18.8bn, adjusted EBITDA up 2% to AED4.3bn and net profit up 81% to AED3.8bn.
However, the profit surge was largely driven by AED1.1bn of unrealized fair-value gains in Alpha Wave Ventures II, while operating momentum was modest and earnings remained heavily reliant on Aldar; the stock’s sub-8x P/E and 1.2x P/B are attractive, but not sufficient for a clean buy amid regional disruption and execution risk.
Themes
- Q1 2026 Results
- Alpha Wave Ventures
- Fair Value Gains
- Aldar Concentration
- Regional Uncertainty
- M And A
Near term
Regional uncertainty remains a near-term risk to hospitality, restaurants, construction milestones and EPC activity; restaurant operations had recovered only to about 60% of pre-disruption levels.
NMDC and Trojan reported lower profit despite revenue growth, with management attributing the weakness to timing, project delays and regional conditions.
The AED1bn 2026 buyback has barely commenced, with only AED7.9m completed and AED992m remaining at the time of the call.
Near-term reported earnings could remain volatile as Alpha Wave fair values move with private-market financing rounds and potential IPO outcomes.
Longer term
The portfolio has meaningful multi-year visibility, with NMDC, Aldar, Pure Health and Trojan collectively generating over AED100bn of last-twelve-month revenue and holding more than AED165bn of backlog.
Management is targeting AED8bn of M&A in 2026 and a 15% ROE hurdle, with stated underweight areas including energy, hospitality and financial services; returns will depend on disciplined deployment rather than simply expanding the portfolio.
The AED42.4bn cash balance and 0.15x net-debt-to-EBITDA provide substantial capacity for acquisitions, investment and shareholder returns.
Wio, Enersol, MICAD and other growth-stage assets could diversify earnings over time, but their contribution is currently small and their path to material profitability remains unproven.
Red flags
The 81% net-profit increase was primarily a comparison effect against a Q1 2025 fair-value loss and a Q1 2026 AED1.1bn Alpha Wave gain; management explicitly acknowledged the gain is non-cash and non-recurring.
Real estate, principally Aldar, was a dominant profit contributor in Q1. Management characterized this as temporary, but did not quantify the expected earnings mix or recovery timeline for weaker sectors.
NMDC and Trojan experienced profit declines, while Pure Health net profit also fell slightly; management’s explanation that this is temporary timing remains insufficiently quantified.
Alpha Wave’s valuation uplift includes exposure to SpaceX, OpenAI, Anthropic and Cerebras, creating sensitivity to private-market valuation resets and uncertain liquidity or IPO outcomes.
The call contained limited analyst pushback and no detailed disclosure on segment margins, cash conversion, acquisition pipeline quality or the valuation discount to NAV, limiting confidence in the holding-company discount argument.
Forward outlook
ebitda
20.5 $billion
FY 2026
official guidance
Recommendation history
OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.
Earnings transcripts
Documents
FormReporting forFiledFlags